Table 3.
Perception of general and COVID-19 vaccine safety among participants (n = 1,367). Note that COVID-19 vaccines were not differentiated by specific product.
| General vaccine safety perception (0–100) | COVID-19 vaccine safety perception (0–100) | |||
|---|---|---|---|---|
| Mean (SEM) | P | Mean (SEM) | P | |
| Total | 84.5 (0.51) | 74.2 (0.67) | ||
| Sex | <0.001 | 0.002 | ||
| Male | 86.6 (0.74) | 76.7 (1.03) | ||
| Female | 83.2 (0.68) | 72.6 (0.87) | ||
| Age (years) | <0.001 | 0.015 | ||
| <30 | 87.1 (0.68) | 77.0 (0.92) | ||
| 30–49 | 83.8 (0.97) | 71.3 (1.28) | ||
| 50+ | 81.6 (1.12) | 72.9 (1.39) | ||
| Education | <0.001 | <0.001 | ||
| < Bachelor's degree | 80.4 (0.87) | 67.3 (1.12) | ||
| Bachelor's degree | 87.2 (0.71) | 78.8 (0.92) | ||
| > Bachelor's degree | 89.4 (0.86) | 82.2 (1.22) | ||